<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0019">
 <label>19.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Du</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>He</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhou</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zheng</surname>
    <given-names>BJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Jiang</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <article-title>The spike protein of SARS-CoV–a target for vaccine and therapeutic development</article-title>. 
  <source>Nat Rev Microbiol</source>. 
  <year>2009</year>;
  <volume>7</volume>(
  <issue>3</issue>):
  <fpage>226</fpage>–
  <lpage>36</lpage>. doi:
  <pub-id pub-id-type="doi">10.1038/nrmicro2090</pub-id>.
  <pub-id pub-id-type="pmid">19198616</pub-id>
 </mixed-citation>
</ref>
